Harvard Men's Health Watch

PSA: Prostate-Specific Antigen, Persisting Scientific Ambiguities

The prostate-specific antigen (PSA) test can detect prostate cancer early enough for treatment, but it cannot determine whether the cancer is aggressive or indolent, and overdiagnosis is its biggest drawback.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In